Evidence map›Paper›PMID 42789081›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

The prognostic value of quantitative myocardial blood flow and flow reserve by dynamic CZT-SPECT for major adverse cardiovascular events.

Yu-Cheng Shih, Shan-Ying Wang, Yu-Chien Shiau, Yen-Wen Wu

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yu-Cheng ShihDepartment of Nuclear Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Shan-Ying WangDepartment of Nuclear Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Yu-Chien ShiauDepartment of Nuclear Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Yen-Wen WuDepartment of Nuclear Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan. wuyw0502@gmail.com.ORCID http://orcid.org/0000-0003-1520-1166

Funding

Far Eastern Memorial Hospital 104-2314-B-418-008, 105-2325-B-418-001, 105-2628-B-418-002-MY2, 107-2314-B-418-006-MY3, 108-2314-B-418-002-MY3, and 111-2314-B-418-006-MY3Far Eastern Memorial Hospital FEMH-2026-C-094Ministry of Science and Technology of Taiwan MOST104-2314-B-418-008, 105-2325-B-418-001, 105-2628-B-418-002-MY2, 107-2314-B-418-006-MY3, 108-2314-B-418-002-MY3, and 111-2314-B-418-006-MY3
6 · The paper itself

Abstract

purposeCadmium-zinc-telluride single-photon emission computed tomography (CZT SPECT) enables myocardial blood flow (MBF) quantification using

methodsWe retrospectively included 1,007 consecutive patients who underwent dynamic [

resultsDuring a median follow-up of 49 months, MACEs occurred in 191 patients (19.0%). The optimal cutoffs were 1.96 mL/g/min for stress MBF and 1.98 for MFR. Abnormal flow was associated with worse MACE-free survival (χ² = 87.2, p < 0.001). In multivariable analysis, MFR and resting MBF remained independent predictors of a MACE after adjusting for clinical risk factors, stress left ventricular ejection fraction, and stress total perfusion deficit (sTPD). Quantitative flow assessment provided incremental risk stratification in patients with sTPD < 15%.

conclusionCZT SPECT-derived MBF and MFR provided independent prognostic information beyond conventional risk factors and static perfusion assessment, supporting their role in refining clinical risk stratification.

Indexed as

CZT SPECTMajor Adverse Cardiovascular Events (MACEs)Myocardial Blood Flow (MBF)Myocardial Flow Reserve (MFR)Prognosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.